Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".


Yilmaz M., Elmali A., Yazici G.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, cilt.25, ss.2060-2062, 2019 (SCI-Expanded) identifier identifier identifier